Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Tokuda

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
The Tokai Journal of Experimental and Clinical Medicine|September 6, 2017
Pyoderma Gangrenosum after Breast Mastectomy and Primary Rectus Abdominis Flap ReconstructionYasuhiro Suzuki, Kozue Yokoyama, Mayako Terao, et al.
Japanese Journal of Clinical Oncology|December 22, 2018
A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapyAkihiko Osaki, Kenichi Inoue, Hiroshi Sakai, et al.
Cancer Science|April 28, 2012
Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancerNaoki Niikura, Takayuki Iwamoto, Shinobu Masuda, et al.
Japanese Journal of Clinical Oncology|July 17, 2013
The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancerYoshiaki Sagara, Kazuhiko Sato, Eisuke Fukuma, et al.
Breast Cancer Research and Treatment|July 22, 2023
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03)Kokoro Kobayashi, Norikazu Masuda, Toshiro Mizuno, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2020
Taste alterations in patients with breast cancer following chemotherapy: a cohort studyYuya Denda, Naoki Niikura, Shizuko Satoh-Kuriwada, et al.
Breast Cancer (Tokyo, Japan)|December 18, 2004
A multicenter phase II study of docetaxel 60 mg/m2 as first-line chemotherapy in patients with advanced or recurrent breast cancerTakashi Ishikawa, Satoru Shimizu, Masaaki Inaba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumorsNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
Breast Cancer (Tokyo, Japan)|May 2, 2022
Correction to: Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trialHitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|December 13, 2005
[A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients]Masamichi Nishio, Muneaki Sano, Yoshio Tamaki, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
The Tokai Journal of Experimental and Clinical Medicine|September 6, 2017
Pyoderma Gangrenosum after Breast Mastectomy and Primary Rectus Abdominis Flap ReconstructionYasuhiro Suzuki, Kozue Yokoyama, Mayako Terao, et al.
Japanese Journal of Clinical Oncology|December 22, 2018
A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapyAkihiko Osaki, Kenichi Inoue, Hiroshi Sakai, et al.
Cancer Science|April 28, 2012
Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancerNaoki Niikura, Takayuki Iwamoto, Shinobu Masuda, et al.
Japanese Journal of Clinical Oncology|July 17, 2013
The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancerYoshiaki Sagara, Kazuhiko Sato, Eisuke Fukuma, et al.
Breast Cancer Research and Treatment|July 22, 2023
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03)Kokoro Kobayashi, Norikazu Masuda, Toshiro Mizuno, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2020
Taste alterations in patients with breast cancer following chemotherapy: a cohort studyYuya Denda, Naoki Niikura, Shizuko Satoh-Kuriwada, et al.
Breast Cancer (Tokyo, Japan)|December 18, 2004
A multicenter phase II study of docetaxel 60 mg/m2 as first-line chemotherapy in patients with advanced or recurrent breast cancerTakashi Ishikawa, Satoru Shimizu, Masaaki Inaba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumorsNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
Breast Cancer (Tokyo, Japan)|May 2, 2022
Correction to: Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trialHitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|December 13, 2005
[A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients]Masamichi Nishio, Muneaki Sano, Yoshio Tamaki, et al.
Pageof 13